SEGUIDORES

free counters online counter

ARTÍCULOS DE INTERÉS PARA MÉDICOS


Cuando un paciente se va. El duelo medico.

Dr. Guillermo Fco. Rosales Magallanes
Pediatra Infectologo

Un tema dificil de abordar, en medicina parte de la formacion medica implica el evitar el fraternizar, deben saber que la corriente de la medicina ortodoxa implica esto, sin embargo a traves del tiempo el medico ha cambiado, existen mas personas que se involucran de manera empatica en sus pacientes esto fortalece la relacion medico/paciente, pero por otro lado nos hace caer en el mismo circulo de duelo (quiza en distinta magnitud) de como lo vive la familia. Te invitamos a seguir leyendo.

Como medicos tenemos limitaciones, debemos enfrentar las mismas situaciones de vida que el resto de la gente, tenemos una familia, falta de tiempo, nos estresamos al compartir el mismo mundo que el de nuestros pacientes, no nos hace especiales absolutamente nada, no estamos excentos de accidentes ni de circunstancias de vida distintas a las de cualquier otra persona, aun asi el paciente se ha habituado a ver la figura medica como aquel que tiene la obligacion de resolver, se nos brinda mas confianza de la debida y en ocasiones ponen al medico en un altar innegable. Deben saber que a lo largo de nuestras carreras hemos librado una batalla invisible contra la muerte, contra el tiempo y hemos enfrentado la penosa tarea de dar una noticia de muerte, pueden creer que somos personas de caracter reacio, fuertes sin embargo no es una vida completamente normal la que vivimos, enfrentamos mas situaciones de muerte que las que una persona promedio, es una carga moral la que constantemente vivimos. No es sencillo ser medico y tener como pediatra que dar una noticia de esta magnitud, cursamos con una carga emocional terrible que puede durar hasta un mes, somos padres de familia, somos hermanos y somos hijos tambien.

Como medicos no estamos excentos a sufrir con nuestros pacientes y pasamos por fases de duelo en menor escala, que de alguna manera merman nuestra actividad profesional, cada paciente es una carga moral, pero entendemos que tenemos limitaciones, no nos vean como esas personas fuertes, somos en ocasiones mas debiles de lo que creen, aun asi aqui estamos y cada paciente recuperable que logra vencer la muerte (y al referirme que logra vencerla, es darle el completo credito al paciente y a la vida que le brindo otra oportunidad) es un logro mas para nosotros, no pretendemos ganar ningun premio, somos igual que cualquier otra persona, no esperamos ganar el cielo solo que aprendan a ver al medico como el ser humano que dia a dia lucha con ustedes, sufre con ustedes los padecimientos de sus hijos.

Esperamos sus comentarios. mundopediatria@gmail.com



Mass Polio Vaccination Campaign Kicks Off in S. Sudan

Source: Sudan Tribune
By: Uma, Julius N.
11/07/2011

South Sudan has launched a mass polio vaccination campaign targeting approximately 3 million children under the age of five years old. Each child will be administered at least two drops of the polio vaccine during the campaign, which will run through Nov. 12. “The polio campaign is very timely in that it remains in line with the health ministry’s 100 days program of effective service delivery initiated by President Salva Kiir,” says Dr. Michael Millie Hussein, health minister for Africa’s newest nation. According to reports, more than 720,000 children have benefited from the campaign, which is believed to have achieved 72 percent coverage across the country. South Sudan’s last case of polio was reported 27 months ago. The nation will need to conduct the immunization campaign four times a year to eradicate the deadly disease. South Sudan partnered with UNICEF, World Health Organization, U.S. Agency for International Development, the Japanese government, and the Centers for Disease Control and Prevention.



Studies Show Glaxo's HPV Vaccine Fights Cervical Cancer

Source: Dow Jones Newswires
By: Stovall, Sten
11/08/2011
Two studies published in the online version of The Lancet Oncology indicate that GlaxoSmithKline’s Cervarix vaccine, when given to girls before they become sexually active, is effective in preventing the human papillomavirus (HPV). The vaccine specifically targets HPV types 16 and 18, which account for 70 percent of cervical cancers, but research indicates that it may protect against four other types of HPV. A study of 20,000 women in 14 countries between the ages of 15 and 25 who had never been infected with HPV found that Cervarix was 93 percent effective in preventing CIN3+, or advanced precancerous lesions. The European label for Cervarix has been updated to include these findings
Identifying Malaria's Achilles' Heel

Source: BBC News
By: Feilden, Tom
11/10/2011
A study published in the journal Nature reveals that researchers at the Wellcome Trust’s Sanger Institute have identified a key interaction between a single receptor on the surface of the blood cell and a protein on the parasite that causes malaria. This finding could pave the way for the development of an effective malaria vaccine that blocks this interaction. “Because we know this interaction is essential, we could vaccinate with one component of that interaction, the parasite protein,” says Dr. Julian Rayner. “Then people would be pre-primed with antibodies so that when the parasites emerged into their bloodstream, the immune system would be there ready to stop them invading red blood cells.” Given that around 50 percent of the global population is at risk of malaria, experts say a vaccine would be the simplest and most cost-effective prevention strategy. GlaxoSmithKline’s Mosquirix vaccine is in the last stages of clinical testing, with early trials showing 50 percent effectiveness, but Rayner says a vaccine based on the study’s findings could be even more effective. Oxford University scientists are already working with the Sanger Institute on a vaccine, with Rayner hoping that the first trials on humans will begin in two years.




CDC Still Listening to Youth Vaccination Debate

Source: Los Angeles Times
By: Cullotta, Karen Ann
07/27/2011
Passionate opinions arose at a recent health forum in Chicago, sparked by the debate about the possibility of federal recommendations that babies be vaccinated against meningitis. The U.S. Centers for Disease Control and Prevention (CDC) currently recommends meningitis vaccination for children ages 11 to 18 years, but the U.S. Food and Drug Administration recently approved a vaccine for babies as young as nine months of age. Federal officials are now considering adding the vaccine to the 16 immunizations now on the CDC recommendation schedule. The CDC is seeking public input about this latest proposed addition. The recent event in Chicago, co-sponsored by the CDC and the Chicago Area Immunization Campaign, was the third of four public discussions across the United States. “The CDC has never done this before,” said Glen Nowak, senior adviser for the CDC’s National Center for Immunization and Respiratory Diseases. “We’ve done public education about pandemics and vaccines, but now we’re talking about who should get this vaccine. We’re trying to see, Are people skeptical? Or do they think this is a good idea, and why?” Any changes to state immunization recommendations and requirements ultimately will be decided by state agencies; the CDC can recommend immunizations but does not have the legal ability to require them, Nowak noted.


MMR Vaccine Take-Up on the Rise After Declining for Years

Source: London Guardian (United Kingdom)
By: Meikle, James
07/26/2011
The number of children under two years in the United Kingdom who have received the MMR vaccine has risen to the highest level in more than a decade. The vaccination rate has risen above 90 percent across the United Kingdom, with rates of at least 90 percent reported in Scotland, Wales, Northern Ireland, and six regions of England, as reported by the Health Protection Agency (HPA). Unlike in the United States, the vaccine is not required for children in the United Kingdom. Experts report that 85.1 percent of children between ages three and five years have received the booster shot, a level that can be attributed to the changing attitude of parents toward the vaccine and more health professionals following up with unvaccinated children. Mary Ramsay of the HPA’s immunization department says, “The aim now is getting it as high as possible and keeping it as high as possible. If we can get coverage up at two and five years we still need to keep up with (unvaccinated) people before they leave school. Once they leave school they are quite difficult to get hold of.” Of the 654 confirmed measles cases in England and Wales through June, nearly 67 percent were in London and southern England, which have the lowest MMR vaccination rates.

Nigeria: FG to Introduce New Meningitis Vaccine

Source: allAfrica.com
By: Okafor, Judd Leonard
07/26/2011
http://www.immunizationinfo.org/es/pressroom/news-brief

Nigeria plans to roll out the MenAfriVac and Haemophilus influenza type B (Hib) vaccines later this year in an effort to protect millions of people from the devastating effects of cerebrospinal meningitis. The World Health Organization and its PATH partner in the Meningitis Vaccine Project developed MenAfriVac specifically for Africa. Mali and Burkina Faso introduced the vaccine last year. An estimated 100 million cases of the disease have been reported in Nigeria. The Hib vaccine will be added to four existing routine vaccines in a single injection to make a pentavalent vaccine. The single injection would protect against Hib, diphtheria, whooping cough, tetanus and hepatitis B. Nigeria will administer the pentavalent vaccine in phases between 2011 and 2013 until it becomes part of the routine national immunization program.



MAS INFORMACION EN:
http://www.immunizationinfo.org/es/pressroom/news-brief